Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.
2.

[The origins of analysis and of drugs control].

Lafont O.

Ann Pharm Fr. 2017 Jul;75(4):302-308. doi: 10.1016/j.pharma.2017.02.003. Epub 2017 Mar 30. French.

PMID:
28366205
3.

[Greek science in the centre of the Dialogue between Orient and Occident ].

Lafont O.

Rev Hist Pharm (Paris). 2016 Dec;64(392):503-18. French.

PMID:
29611909
4.
5.

[Christophle Glaser, one of Lemery’s].

Lafont O.

Rev Hist Pharm (Paris). 2016 Sep;64(391):419-32. French.

PMID:
29611686
6.

[Nicolas Lemery, a pluridisciplinary Scientist].

Lafont O.

Rev Hist Pharm (Paris). 2016 Sep;64(391):329-42. French.

PMID:
29611677
7.

[The complex travel of cinchona barks between Peru and Québec Hôtel-Dieu, in the middle of the eighteenth century].

Simon L, Lafont O.

Rev Hist Pharm (Paris). 2016 Mar;64(389):53-8. French.

PMID:
27281933
8.

The copy of the Essays of Jean Rey, used by Bayen and Gobet, at the BIU Sante, pole Pharmacie.

Lafont O.

Rev Hist Pharm (Paris). 2016 Jun;64(390):193-202. English, French.

PMID:
29485777
9.

[The presence of charity books in the inventory of the College of Pharmacy].

Lafont O.

Rev Hist Pharm (Paris). 2015 Dec;63(388):461-72. French.

PMID:
26827553
10.

[The gift of pharmacopoeias made by Mésaize to the Society of Pharmacists of Rouen].

Lafont O, Vettes J.

Rev Hist Pharm (Paris). 2015 Dec;63(388):379-90. French.

PMID:
26827548
11.

[How to become a pharmacist via the medical juries, during the Consulate and the Empire].

Lafont O.

Rev Hist Pharm (Paris). 2015 Sep;63(387):319-32. French.

PMID:
26529887
12.

[A handwritten inscription leading to new information].

Lafont O.

Rev Hist Pharm (Paris). 2015 Jun;63(386):183-90. French.

PMID:
26189308
13.

[The Library of the Franciscan pharmacy in Jerusalem].

Lafont O.

Rev Hist Pharm (Paris). 2015 Mar;62(385):7-19. French.

PMID:
26043460
14.

[Pierre Bayen rediscovers the Essays of Jean Rey].

Lafont O.

Rev Hist Pharm (Paris). 2014 Oct;62(383):343-50. French.

PMID:
25671980
15.

[The birth of two classes of pharmacists, aborted in 1825, but accomplished in 1854].

Lafont O, Istin C.

Rev Hist Pharm (Paris). 2014 Jan;62(381):29-38. French.

PMID:
25668910
16.

[Vauquelin: route from a thatched cottage to Institute of France].

Lafont O.

Ann Pharm Fr. 2014 Jul;72(4):221-8. doi: 10.1016/j.pharma.2014.02.001. Epub 2014 Mar 4. French.

PMID:
24997883
17.

[Parmentier hygiene and public health].

Lafont O.

Ann Pharm Fr. 2014 May;72(3):194-201. doi: 10.1016/j.pharma.2013.12.007. Epub 2014 Jan 21. French.

PMID:
24780835
18.

New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (I). Synthesis and preliminary screening: evaluation of the detoxification using a half-quantitative enzymatic assay.

Kalakuntla RK, Wille T, Le Provost R, Letort S, Reiter G, Müller S, Thiermann H, Worek F, Gouhier G, Lafont O, Estour F.

Toxicol Lett. 2013 Feb 4;216(2-3):200-5. doi: 10.1016/j.toxlet.2012.11.020. Epub 2012 Nov 29.

PMID:
23201439
19.

New modified β-cyclodextrin derivatives as detoxifying agents of chemical warfare agents (II). In vitro detoxification of cyclosarin (GF): general screening and toxicokinetic aspects of OP scavengers.

Müller S, Estour F, Kalakuntla RK, Le Provost R, Lafont O, Worek F, Thiermann H, Reiter G.

Toxicol Lett. 2013 Feb 4;216(2-3):206-12. doi: 10.1016/j.toxlet.2012.11.019. Epub 2012 Nov 29.

PMID:
23201438
20.

Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.

Estour F, Letort S, Müller S, Kalakuntla RK, Le Provost R, Wille T, Reiter G, Worek F, Lafont O, Gouhier G.

Chem Biol Interact. 2013 Mar 25;203(1):202-7. doi: 10.1016/j.cbi.2012.10.020. Epub 2012 Nov 2.

PMID:
23123247
21.

[Helen of Troy and medicine, a picture of the "Salle des Actes"].

Lafont O.

Rev Hist Pharm (Paris). 2012 May;60(373):7-16. French.

PMID:
23045808
22.

[The opinion of Herman Boerhaave on medicines, through a non-authorized book].

Lafont O.

Rev Hist Pharm (Paris). 2011 Jul;59(370):221-34. French.

PMID:
21998972
23.

[Boerhaave and medication].

Lafont O.

Hist Sci Med. 2011 Apr-Jun;45(2):127-9. French.

PMID:
21936213
24.

[Theriacs in charity books, during the 17th and the 18th centuries].

Lafont O.

Rev Hist Pharm (Paris). 2010 Oct;58(367):311-8. French.

PMID:
21560366
25.

Optimized strategies to synthesize β-cyclodextrin-oxime conjugates as a new generation of organophosphate scavengers.

Le Provost R, Wille T, Louise L, Masurier N, Müller S, Reiter G, Renard PY, Lafont O, Worek F, Estour F.

Org Biomol Chem. 2011 Apr 21;9(8):3026-32. doi: 10.1039/c0ob00931h. Epub 2011 Mar 4.

PMID:
21373706
26.

In vitro detoxification of cyclosarin (GF) by modified cyclodextrins.

Müller S, Koller M, Le Provost R, Lafont O, Estour F, Wille T, Thiermann H, Worek F, Reiter G.

Toxicol Lett. 2011 Jan 15;200(1-2):53-8. doi: 10.1016/j.toxlet.2010.10.014. Epub 2010 Oct 28.

PMID:
21035528
27.

[Lady's work and bestseller: the remedies of Madame Fouquet].

Lafont O.

Rev Hist Pharm (Paris). 2010 Apr;58(365):57-72. French.

PMID:
20533809
28.

[Nicolas Lémery, salvation of bibliophiles].

Lafont O.

Rev Hist Pharm (Paris). 2009 Oct;57(363):267-76. French.

PMID:
20481122
29.

[Bibliophilism or bibliomania?].

Lafont O.

Rev Hist Pharm (Paris). 2009 Oct;57(363):247-54. French.

PMID:
20481120
30.

Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay.

Wille T, Tenberken O, Reiter G, Müller S, Le Provost R, Lafont O, Estour F, Thiermann H, Worek F.

Toxicology. 2009 Nov 30;265(3):96-100. doi: 10.1016/j.tox.2009.09.018. Epub 2009 Oct 1.

PMID:
19800384
31.

Regioselective access to 3I-O-substituted-beta-cyclodextrin derivatives.

Masurier N, Lafont O, Le Provost R, Lesur D, Masson P, Djedaïni-Pilard F, Estour F.

Chem Commun (Camb). 2009 Feb 7;(5):589-91. doi: 10.1039/b812325j. Epub 2008 Dec 5.

PMID:
19283300
32.

[The role plaid by the port of Rouen in the trade of drugs and medicines with America].

Lafont O.

Rev Hist Pharm (Paris). 2008 Nov;56(359):305-10. French.

PMID:
19230506
33.

[The scientific career of Scheele cannot be reduced to chlorine discovery].

Lafont O.

Rev Hist Pharm (Paris). 2008 Feb;55(356):467-72. French.

PMID:
18549186
34.

[From apprenticeship to Nobel Prize: Henri Moissan's fabulous destiny].

Lafont O.

Ann Pharm Fr. 2008 Jan;66(1):28-33. doi: 10.1016/j.pharma.2007.12.004. Epub 2008 Apr 2. French.

PMID:
18435983
35.

[From the powder of the comtessa to quinine: the saga of quinquina].

Lafont O.

Veroff Schweiz Ges Gesch Pharm. 2007;28:103-12. French. No abstract available.

PMID:
18351220
36.

[From the willow to aspirin].

Lafont O.

Rev Hist Pharm (Paris). 2007 Jul;55(354):209-16. French.

PMID:
18175528
37.

Investigation of N-hydroxythalidomide in vitro stability and comparison to other N-substituted derivatives.

Estour F, Ferranti V, Chabenat C, Toussaint E, Galons H, Lafont O.

J Pharm Biomed Anal. 2007 Oct 18;45(2):237-42. Epub 2007 Jun 14.

PMID:
17656059
38.

[Life and death of free radicals].

Lafont O.

Rev Hist Pharm (Paris). 2007 Jan;54(352):475-8. French.

PMID:
17575842
39.

[Lavoisier and radicals].

Lafont O.

Rev Hist Pharm (Paris). 2007 Jan;54(352):447-52. French.

PMID:
17575840
40.

[Alchemists' humid radical].

Lafont O.

Rev Hist Pharm (Paris). 2007 Jan;54(352):441-6. French.

PMID:
17575839
41.

[Where it is shown that a quarrel about precedence can lead to the Holy Bible].

Lafont O.

Rev Hist Pharm (Paris). 2006 Nov;54(351):307-12. French.

PMID:
17526143
42.

[Substituted cyclodextrins: an example of biomimetic catalyzers].

Masurier N, Lafont O, Estour F.

Ann Pharm Fr. 2007 Mar;65(2):126-33. Review. French.

PMID:
17404546
43.

Improved access to 2-O-monobenzyl ethers of beta-cyclodextrin as precursors of catalysts for organophosphoryl esters hydrolysis.

Masurier N, Estour F, Lefèvre B, Brasme B, Masson P, Lafont O.

Carbohydr Res. 2006 May 22;341(7):935-40. Epub 2006 Mar 10.

PMID:
16530173
44.

[The Book of the Eparch, by Leo VI: interest for the history of pharmacy].

Lafont O.

Rev Hist Pharm (Paris). 2005 Jan;53(346):247-56. French.

PMID:
16217898
45.

Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.

Masurier N, Estour F, Froment MT, Lefèvre B, Debouzy JC, Brasme B, Masson P, Lafont O.

Eur J Med Chem. 2005 Jul;40(7):615-23. Epub 2005 Apr 1.

PMID:
15935896
46.

[Porphyrin catalysts: a tool for preparation of metabolite models].

Estour F, Akagah B, Ségrestaa J, Vérité P, Ménager S, Lafont O.

Ann Pharm Fr. 2004 Sep;62(5):297-303. Review. French.

PMID:
15314576
47.

Aminoglutethimide included in nanocapsules suspension: comparison of GC-MS and HPLC methods for control.

Berrabah M, Andre D, Verite P, Zahidi A, Lafont O.

J Pharm Biomed Anal. 2004 Jun 29;35(4):761-8.

PMID:
15193720
48.

Regio- and diastereocontrolled preparative oxidation of methyloctalones by a biomimetic porphyrin catalyst.

Akagah B, Estour F, Vérité P, Lameiras P, Nour M, Cavé C, Ménager S, Lafont O.

Chirality. 2004 Jul;16(6):398-403.

PMID:
15190585
49.

[Evolution of pharmaceutical regulations from the origins to Germinal law].

Lafont O.

Rev Hist Pharm (Paris). 2003;51(339):361-76. French.

PMID:
14763458
50.

[Latin and the training of apothecaries in France].

Lafont O.

Rev Hist Pharm (Paris). 2000;48(327):345-50. French.

PMID:
14653270

Supplemental Content

Loading ...
Support Center